Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma

被引:20
作者
Hai, S [1 ]
Kubo, S
Yamamoto, S
Uenishi, T
Tanaka, H
Shuto, T
Takemura, S
Yamazaki, O
Hirohashi, K
机构
[1] Osaka City Univ, Grad Sch Med, Dept Hepato Biliary Pancreat Surg, Osaka 558, Japan
[2] Osaka City Gen Hosp, Dept Gastrointestinal Surg, Osaka, Japan
关键词
hepatitis C virus; intrahepatic cholangiocarcinoma; liver resection;
D O I
10.1159/000091446
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Although hepatitis C virus (HCV) infection is a possible pathogenetic factor for intrahepatic cholangiocarcinoma (ICC), clinicopathologic features of ICC patients with HCV infection remain unclear. Patients and Methods: Of 50 patients with ICC treated, 19 were infected with HCV (HCV-positive group) and 38 underwent surgical treatment. Clinicopathologic features and postoperative outcome were compared between patients with and without HCV infection. Results: In 15 patients in the HCV-positive group, ICC was detected during follow-up for chronic hepatitis C. The proportion of patients who underwent curative resection was significantly higher in the HCV-positive than in the HCV-negative group, and tumors were significantly smaller in the HCV-positive than in the HCV-negative group. In the HCV-positive group, tumors were significantly smaller in patients who were followed up for chronic hepatitis C than in patients who were not followed up. Although cumulative survival rates did not cliff er significantly between groups, prognoses of patients with small ICC were significantly better than those with large ICC. Conclusion: Follow-up for patients with chronic hepatitis C by imaging series at regular intervals is important and provides the possibility to detect a small ICC as well as a hepatocellular carcinoma. Resection should be guided by liver function and the tumor stage in patients with HCV-associated ICC. Copyright (c) 2005 S. Karger AG, Basel.
引用
收藏
页码:432 / 439
页数:8
相关论文
共 35 条
  • [1] [Anonymous], 1990, ANN SURG, V211, P277
  • [2] BHUIYA MMR, 1992, ANN SURG, V215, P344
  • [3] Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
    Burak, K
    Angulo, P
    Pasha, TM
    Egan, K
    Petz, J
    Lindor, KD
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (03) : 523 - 526
  • [4] Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure
    Eguchi, H
    Umeshita, K
    Sakon, M
    Nagano, H
    Ito, Y
    Kishimoto, SI
    Dono, K
    Nakamori, S
    Takeda, T
    Gotoh, M
    Wakasa, K
    Matsuura, N
    Monden, M
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (07) : 1383 - 1388
  • [5] EVIDENCE FOR A HEPATOCELLULAR LINEAGE IN A COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA OF TRANSITIONAL TYPE
    FISCHER, HP
    DOPPL, W
    OSBORN, M
    ALTMANNSBERGER, M
    [J]. VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1988, 56 (02) : 71 - 76
  • [6] Hirohashi K, 2002, HEPATO-GASTROENTEROL, V49, P806
  • [7] *IHPBA, 2000, HPB, V2, P33
  • [8] Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma
    Inoue, K
    Makuuchi, M
    Takayama, T
    Torzilli, G
    Yamamoto, J
    Shimada, K
    Kosuge, T
    Yamasaki, S
    Konishi, M
    Kinoshita, T
    Miyagawa, S
    Kawasaki, S
    [J]. SURGERY, 2000, 127 (05) : 498 - 505
  • [9] Kobayashi M, 2000, CANCER, V88, P2471, DOI 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO
  • [10] 2-T